Endogenous CD4(+) T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic KRAS and ERBB2 (Her2) Driver Mutations.
Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton AM, Riddell SR
Cancer Immunol Res. 2019 Jun;7(6):910-922. doi: 10.1158/2326-6066.CIR-18-0402. Epub 2019 May 1.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 124250 | pJV126 | In vitro transcription plasmid for T7 transcription of wildtype Her2 sequence targeted to the endosome. Linearize with SapI. |
| 124251 | pJV127 | In vitro transcription plasmid for T7 transcription of Her2 ITD sequence targeted to the endosome. Linearize with SapI. |
| 124252 | pJV128 | In vitro transcription plasmid for T7 transcription of KRAS WT sequence targeted to the endosome. Linearize with SapI. |
| 124253 | pJV129 | In vitro transcription plasmid for T7 transcription of KRAS G12V sequence targeted to the endosome. Linearize with SapI. |
| 124254 | pJV132 | Lentiviral vector (pRRL) containing KRAS G12V specific T cell receptor, clone 3 |
| 124255 | pJV136 | Lentiviral vector (pRRL) containing KRAS G12V specific T cell receptor, clone 9 |
| 124256 | pJV137 | Lentiviral vector (pRRL) containing Her2-ITD specific T cell receptor |